Welcome
Support Centre
06 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A study of the influence of pheromones on superosmia
ISRCTN ISRCTN61835374
ClinicalTrials.gov identifier
Public title A study of the influence of pheromones on superosmia
Scientific title
Acronym N/A
Serial number at source N0274181493
Study hypothesis The aim of this study is to evaluate the whether pheromones can influence the occurrence of superosmia during an olfactory threshold test.
Lay summary
Ethics approval Added September 2008: UCLH Committee (UK), ref 06/Q0505/10, 04/08/06 (Ethics Approval), 18/05/07 (R&D Approval).
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Ear, Nose and Throat: Superosmia
Participants - inclusion criteria Anyone who considers themselves to have a normal sense of smell.
Participants - exclusion criteria People who are found to be hyposmic/anosmic (ie lacking in ability to detect odours at normal levels), people with sino-nasal disease, people unable to understand spoken English or who are mentally impaired.
Anticipated start date 11/08/2008
Anticipated end date 01/08/2009
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Number of participants: 100 total. 50 from West Suffolk.
Interventions The study will take place at the ENT departments of Leicester Royal Infirmary and the West Suffolk Hospital. One hundred subjects will be recruited from amongst hospital staff who consider themselves to have a 'normal' sense of smell and no active sino-nasal disease. The study will take the form of a single-blinded randomised controlled trial. Subjects selected will be invited to undergo a 15 minute smell test and examination of their nose. They will be tested with a computer-driven olfactometer which enables a quantitative threshold test to be performed for several odours: phenethyl alcohol (roses), eucalyptol (menthol), acetic acid (vinegar) and mercaptan (gas). These odours have been shown to represent distinct entities in an individual’s sense of smell (1) and the test format has been validated in our previous work (2). The test involves the patient being seated in front of the olfactometer and the process of the test is explained to them by the researcher. At the voice prompts from the computer attached to the olfactometer, they will be asked to deliver two puffs of air from the spout using the two buttons attached to the olfactometer’s valve. The puffs of air are paired, one being a blank, the other containing the odour and they will be asked to identify the odour repeatedly like this in a forced response format until they have defined a threshold.

Following this they will then be exposed to either a pheromone (delta4,16-androstadien-3-one for female subjects and 1,3,5,(10),16-estratetraen-3-ol for male subjects) or sterile water - 1cm3 of the solution will be placed on a mask and held in front of the subjects nose for 2 minutes. The substance applied to the mask will be determined by use of a closed envelope system. Subjects will be then retested for their olfactory thresholds using the technique described above. This whole process will take less than an hour and no further involvement will be required of the individual subjects.

1. Gaskin JA, Robinson A, Philpott CM, Goodenough PC, Murty GE. Are patients cross-sensitive to odours in parallel threshold tests Chemical Senses 2006
2. Philpott CM, Dhanji F, Wolstenholme CR, Goodenough PC, Clark A, Murty GE. Eucalyptol olfactory threshold testing with a computer driven olfactometer. Journal of Laryngology and Otology 2006
Primary outcome measure(s) Olfactory thresholds
Secondary outcome measure(s) No secondary outcome measures
Sources of funding West Suffolk Hospitals NHS Trust (UK), NHS R&D Support Funding
Trial website
Publications
Contact name Mr  Carl  Philpott
  Address St Paul's Sinus Centre
St Paul's Hospital
1081 Burrard Street
  City/town Vancouver, BC
  Zip/Postcode V6Z 1Y6
  Country Canada
  Tel +1 604 806 9926
  Fax +1 604 806 9690
  Email carl.philpott@btinternet.com
Sponsor University Hospitals of Leicester NHS Trust (UK)
  Address University Hospitals of Leicester NHS Trust Headquarters
Level 3, Balmoral Building
Leicester Royal Infirmary
Infirmary Square,
  City/town Leicester
  Zip/Postcode LE1 5WW
  Country United Kingdom
  Sponsor website: http://www.uhl-tr.nhs.uk/
Date applied 28/09/2007
Last edited 04/11/2010
Date ISRCTN assigned 28/09/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central